The EV maker's shares have formed a new trading range. Something dramatic will need to happen to snap them out of it.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Atlassian Corporation (NASDAQ: TEAM) is up 17% after it reported very strong Q2 FY2025 earnings report. It also revised its ...

Exxon Mobil reported fourth-quarter earnings that beat analysts’ expectations, but the stock fell 0.7% in early trading.

DeepSeek Launch, Intel’s Price Cuts The unveiling of China’s new resource-light AI model, DeepSeek, roiled the U.S. big ...

Apple and other big U.S. companies reporting fatter profits than expected are helping stock indexes shave off more of their ...

Netflix (NASDAQ: NFLX) has been without a doubt one of the best-performing stocks this century. Let's take a closer look at ...

Meta Platforms, Tesla and most other U.S. stocks are rising Thursday following a rush of profit reports from some of the ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Apple Inc. reported record fiscal Q1 earnings, but growth was modest and shares remain expensive despite recent pullback.

Nvidia crossed below its 200-day moving average this week for the first time since 2023. Analysts say the correction could ...